A drug that is used to manage immune diseases in humans and dogs may also be useful in treating a form of bone cancer, according to a recent study.
Researchers found the gold-based drug aurothiomalate kept bone cancer cells from forming in a laboratory setting.
The study also found the drug slowed tumour growth and decreased the spread of cancer to other organs in mice.
Although researchers are hopeful the findings can be used to treat bone cancers in dogs, more tests need to be done before the treatment can be used on humans.
Read more at Michigan State University & University of Florida